EU TRANSPARENCY REGISTER · 334922247628-17 · United States

Novavax

Category

Companies & groups

Country

United States

Gaithersburg

Entity form

Delaware Corporation

Stated objectives

Novavax is a global biotechnology company focused on developing our R&D assets and establishing partnerships to maximize the impact of our cutting-edge technology in protecting health. To learn more, please visit www.novavax.com

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2022-09-14

Last updated

2026-04-30

Other Companies & groups in United States

Other registered organisations in United States

Frequently asked questions

What is this organisation?
Novavax is an interest representative listed in the EU Joint Transparency Register under ID 334922247628-17. Entity form: Delaware Corporation.
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in United States, Gaithersburg.
What are its stated goals?
As declared by the registrant: Novavax is a global biotechnology company focused on developing our R&D assets and establishing partnerships to maximize the impact of our cutting-edge technology in protecting health. To learn more, please visit www.novavax.com
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 334922247628-17.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-08 · Commission Reuse Decision 2011/833/EU